Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
ReproTech Nevada Participates in Fundraising Event to Support Women with Cancer
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), was proud to sponsor the entire staff of the ReproTech Nevada office who participated in Moms on the Run, a fitness organization that raises money to... - May 19, 2019 - ReproTech, LLC
First Responders Unite to End ALS at Inaugural Arrest & Extinguish Event
On May 18th, first responders will unite for a tug-of-war event at Tanglewood to raise money for ALS research. - May 11, 2019 - ALS Therapy Development Institute
Arteric Advances Healthcare Marketing and Engagement Campaigns at Biopharma eMarketing Summit
President and Chief Strategist Shares Two Case Studies That Illustrate How to Leverage Artificial Intelligence to Achieve Business Goals. - May 10, 2019 - Arteric
DDL Diagnostic Laboratory and ENPICOM Join Forces to Deliver Unique Immune Repertoire Sequencing and Data Analysis Services
A full-service offering to accelerate immunotherapy discovery and development. - May 09, 2019 - ENPICOM BV
May is ALS Awareness Month - #AskMeAboutALS
May is ALS Awareness Month. The ALS Therapy Development Institute is inviting the general public to participate, and hoping to inspire a larger dialogue around ALS, through #AskMeAboutALS. - May 01, 2019 - ALS Therapy Development Institute
CloudLIMS’ New Document Management Module Enables Testing Laboratories to Gain ISO/IEC 17025 Accreditation
CloudLIMS releases the Document module for its LIMS to facilitate testing laboratories meet ISO/IEC 17025 accreditation requirements. - April 20, 2019 - CloudLIMS
Save the Date for SMi’s 10th Annual Biosimilars Conference 2019
SMi Group is pleased to announce the next Biosimilars Conference, the first global event taking place at the Copthorne Tara Hotel in London, on 25th and 26th September 2019. - April 18, 2019 - SAE Media Group
More Information About Diseases Risk from Your 23andMe Data
Futura Genetics launches a unique DNA test for 23andMe report data users. Now able to load their genetic information easily and directly, it is possible to discover one’s disease risk results within minutes. - April 12, 2019 - Futura Genetics
Introducing the Read & Understood Training Genius App for Confluence: the First Ever App for Confluence from Life Sciences Quality Assurance Experts Radbee
The Training Genius App features automated, hands-free trainings assignment, empowering QA managers in the medtech, biotech and pharmaceuticals industries to be more productive and compliant. - April 06, 2019 - Radbee
Standigm Raises US $11.5 Million in Series B Round Funding to Advance Its AI-Powered Drug Pipelines Toward License-Out
Standigm, an AI-powered drug discovery company, has raised $11.5 million in a Series B funding round. The funds will be used to scale the AI technology platforms and advance its drug discovery pipelines for untreatable diseases. - March 29, 2019 - Standigm
Understanding Hemophilia for All Ages
Jumo Health and the National Hemophilia Foundation seek to increase health literacy with the release of four evidence-based comic books for those managing hemophilia. - March 28, 2019 - Jumo Health
Daryn Henry Joins Arteric as Creative Director
Veteran Digital Communicator Brings Decades of Award-Winning Experience to Boundary-Pushing Agency. - March 15, 2019 - Arteric
Arteric Explores Current Uses of Artificial Intelligence and Machine Learning to Accelerate Digital NPP Engagement for Biotechnology and OTC Brands
Arteric Shares Case Studies with Life Science Leaders, Illustrating Methods to Increase the Relevance and Authority of Brand Content. - March 14, 2019 - Arteric
New Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy
At just 2-1/4 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for optimizing space in critical microscopy and laboratory applications. - March 14, 2019 - Minus K Technology Inc.
A New Dimension Approach to Peptide Separation by Prof. Xindu Geng from Oasis Publishers
Peptide separation is currently a very active research area that has broad applications in proteomics study of therapeutic peptides, analysis of complex synthetic peptide crude mixtures, and optimization of peptides conditions in on-line comprehensive two-dimensional reversed phase liquid... - March 14, 2019 - Oasis Publishers
Best Health Care Website to be Named by Web Marketing Association in 23rd Annual WebAward Competition
The 23rd annual international WebAward Competition for Web site development at www.webaward.org is now accepting entries. The WebAwards is the standards-defining competition that sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. The deadline for Healthcare websites to enter to is May 31, 2019. - March 12, 2019 - Web Marketing Association
BioTork and Lallemand Biofuels & Distilled Spirits Enter Joint Development Collaboration
BioTork, LLC and Lallemand Biofuels & Distilled Spirits (LBDS) a business unit of Lallemand Inc. are pleased to jointly announce the formalization of a collaboration for the development of improved yeast strains for the ethanol industry. “BioTork has been working with Lallemand, a world... - March 11, 2019 - BioTork
Arteric Guides Healthcare Marketing Leaders on Practical Applications of Artificial Intelligence (AI) to Uncover Unmet Customer Needs
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - March 04, 2019 - Arteric
Christina DiArcangelo Puller Has Been Named a Top 100 Entrepreneur and Will be Featured in the 2019 Top 100 Registry
Christina DiArcangelo Puller, CEO & Founder of Affinity Bio Partners has been selected to the Top 100 Registry Business Leaders and Professionals, in recognition of her work in the Global Biotechnology, Pharmaceuticals, Medical Cannabis and CBD industries. - February 28, 2019 - Top100 Registry Inc.
Apostle Inc. Enters Partnership with Beckman Coulter Life Sciences
Apostle Inc is pleased to announce an exclusive partnership with Beckman Coulter, a world leader in Life Sciences, for Apostle MiniMaxTMHigh Efficiency Cell-Free DNA Isolation Kit. As cell-free DNA (cfDNA) workflows move beyond theoretical and into human health applications, Apostle's industry... - February 28, 2019 - Apostle Inc
Orthopaedic Surgeon Dr. Catherine Logan Performs Centennial Medical Plaza’s First Platelet-Rich Plasma Injection
HCA Healthcare/HealthONE’s Centennial Medical Plaza (CMP) announced that Catherine Logan, MD, MBA, MSPT, a board-certified orthopaedic surgeon, performs Platelet-Rich Plasma (PRP) injections in both the clinic and OR. Dr. Logan is an orthopaedic surgeon specializing in sports medicine,... - February 19, 2019 - The Medical Center of Aurora
Super Brush Receives ISO 13485:2016 Certification
Super Brush LLC, a manufacturing leader in foam swabs and applicators announced today that the company has earned ISO 13485:2016 certification for its quality management system. ISO 13485:2016 certification ensures an organization, such as Super Brush, can consistently meet applicable customer,... - February 15, 2019 - Super Brush LLC
HCA Healthcare/HealthONE’s Swedish Medical Center Hosts Double Open House
Surgery takes center stage with expansion of the hospital’s pre-procedure unit and new robotic-assisted surgical suites. - February 14, 2019 - HCA HealthONE Swedish
Sanyal Biotechnology Hires IQVIA / BuzzeoPDMA DEA Compliance Group
Sanyal Bio has expanded into pre-clinical and clinical contract research on cannabinoids. Sanyal Bio currently holds a DEA Schedule 1 Import License for Cannabis Extracts and THC, with applications pending for Research, Analytical and Manufacturing licenses. IQVIA's DEA Compliance group is well-respected for their expertise and Sanyal Bio looks forward to working with this reputable group going forward. - February 13, 2019 - Sanyal Biotechnology
immunoSCAPE Launches US Office
immunoSCAPE Pte Ltd ("immunoSCAPE" or the "Company"), a leader in immune profiling, today announced the establishment of its first US office in Cambridge, MA. The office will serve as the headquarters of its US based, wholly owned subsidiary immunoSCAPE, Inc. Mr. Choon Peng NG,... - February 11, 2019 - immunoSCAPE Pte Ltd
Academy Medical and Skye Biologics Partner to Strengthen Offering in Federally Funded Medical Facilities
Academy Medical is pleased to announce that Skye Biologics, a national leader in biotechnology, have joined forces to bring validated BioECM tissue biologics to the Department of Veteran’s Affairs (VA), Department of Defense, and Department of Health and Human Services medical centers across the country. - February 07, 2019 - Academy Medical
New Hybrid Genome Assembly Technology Likely to Reshape Gene (DNA) Sequencing Market by Sam Ma from Oasis Publishers
A team from the Kunming Institute of Zoology of the Chinese Academy of Sciences led by Prof. Ya-Ping Zhang & Prof. Zhanshan (Sam) Ma developed a novel hybrid genome assembly technique for the latest third-generation DNA sequencing technologies (3GS). The technique can significantly lower the... - February 05, 2019 - Oasis Publishers
Perthera, Inc. Announces the Appointment of Gary L. Gregory as Chief Executive Officer, President and Board Member
Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts. - February 04, 2019 - Perthera, Inc.
BUHLMANN Diagnostics Corp. Announces New Distribution Agreement with Meridian Biosciences, Inc.
BUHLMANN Diagnostics Corp. has embarked on a new partnership with Meridian Bioscience, Inc. for the distribution of the 510(k) cleared, BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool. - January 31, 2019 - BUHLMANN Diagnostics Corp
Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology
Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology. Romiplostim has been produced with a proprietary and innovative continuous manufacturing... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy
WiCON to Hold Pharma China Annual Forum 2019 in Shanghai on April 9
WiCON International Group LLC, the publisher of well-known WiCON | Pharma China (www.pharmachinaonline.com), announced that it will host the “Pharma China Annual Forum 2019” in Shanghai on April 9. Sponsored by RDPAC and Kantar Health, the well-acclaimed English language event has been... - January 30, 2019 - WiCON International Group LLC
Hans Kaspersetz Joins Digital Pharma West Advisory Board
Digital Marketing Thought Leader to Help Craft Agenda for Leading Healthcare Marketing Conference. - January 25, 2019 - Arteric
Founders of Union Square Hospitality Group, Orangetheory Fitness, Under Armour, United Therapeutics and Sirius XM Satellite Radio to Lead Tony Robbins Business Panel
Held in Palm Beach, the panel will feature leaders in hospitality, fitness and biotechnology. - January 25, 2019 - Tony Robbins
Euphrates Vascular Announces FDA Clearance of the ICHOR Reperfusion System
Euphrates Vascular, a company focused on the treatment of vascular occlusions, recently received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System. ICHOR is designed to treat organized thrombus and embolic events in the peripheral vasculature. This "one size fits all" system is minimally invasive. - January 24, 2019 - Euphrates Vascular
Complimentary Webinar: Data Privacy and Other Clinical Data Management Challenges
CloudLIMS is hosting a complimentary webinar—Data privacy and other clinical data management challenges The webinar will be presented by Marianne Henderson on February 5, 2019, at 9 AM PST. - January 24, 2019 - CloudLIMS
Immunostics Announces the Availability of the Hemochroma PLUS™
FDA 510(k) clearance allows Immunostics to market and sell its new hemoglobin analyzer. - January 23, 2019 - Immunostics Inc.
Pharmaceutical Microbiology UK CONFEX Takes Place in Less Than a Week
SMi reports: Registration will close in less than week, as the countdown begins for the 8th Annual Pharmaceutical Microbiology UK Conference. - January 17, 2019 - SAE Media Group
Global OrthoBiologic Expands Its Operation Under the Name Global REGENERATIVE Group (GRG)
Global OrthoBiologic has announced today that it will expand its operation under the name Global REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida (globalregenerative.group) and will consist of 4 divisions, which will operate independently – Trade, Academy, Care and Finance. - January 16, 2019 - Global Regenerative Group
Cristina Varner Promoted to Life Science National Practice Leader
ABD Insurance and Financial Services announced today the promotion of Cristina Varner to Life Science National Practice Leader. ABD saw significant overall expansion and exceptional performance in 2018, due in large part to the growth and expertise of the Life Science Practice. ABD’s Life... - January 16, 2019 - Newfront
Pulse Therapeutics and ICHOR Vascular Merge to Form Euphrates Vascular
Company aimed at becoming a leader in the treatment of vascular occlusions. - January 13, 2019 - Euphrates Vascular
Bioquark Inc. and Ectocrine Technologies LLC to Collaborate on Mosquito-Derived Health Product Development
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.
ARPA Partners with TacitKey to Elevate and Promote Regulatory Professionals in Asia
TacitKey enables ARPA members to publish and monetize their knowledge of regulatory affairs in Asia. Regulatory professionals can create their knowledge legacy on TacitKey and inspire their peers by organizing webinars as well as training courses. - January 10, 2019 - TacitKey
HedgePath LLC Challenges Fairness of HPPI Commercial License
HedgePath LLC, founder of HedgePath Pharmaceuticals, Inc. (OTC: HPPI) Challenges the Fairness of the Commercial License for the BCCNS Indication Granted by HPPI to the Controlling, Majority Shareholder. - January 03, 2019 - Hedgepath LLC
Kannaki Ramamoorthy Joins Arteric as Quality Assurance Manager
Software-Development Veteran Leads Team Renowned for Impeccable Standards. - December 21, 2018 - Arteric
GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2
GeneFluidics is the only group selected for both NIAID antimicrobial resistance diagnostics projects (https://www.nih.gov/news-events/news-releases/nih-funds-nine-antimicrobial-resistance-diagnostics-projects) and as finalists for the NIH AMR Challenge Step 2 (https://dpcpsi.nih.gov/AMRChallenge/Finalists). - December 05, 2018 - GeneFluidics Inc.
Ambiopharm Announces New Senior Director of Manufacturing
Mukesh Patel joins AmbioPharm Inc as Senior Director of Manufacturing - December 05, 2018 - AmbioPharm
Invitation from James Drinkwater Chairing the 2nd Annual Pharmaceutical Microbiology East Coast Conference
The 2nd Annual Pharmaceutical Microbiology East Coast conference is returning to the Battery Wharf Hotel, Boston, USA on April 10th and 11th, 2019. - December 01, 2018 - SAE Media Group
Silas Kim Joins Arteric as Talent Acquisition Manager
Fills talent pool at rapidly growing healthcare digital marketing agency - November 30, 2018 - Arteric
DNA My Dog Introduces New Canine DNA Test That Identifies Both Genetic Age and Breed of Dogs
DNA My Dog’s novel new NextGen Canine Genetic Age Test is the world’s first commercially available test that uses telomeres to pinpoint a dog’s genetic age, plus identifies the breed through an easy at-home cheek swab. - November 20, 2018 - DNA My Dog
Don Rodriguez Joins Arteric as Director, Analytics & Paid Search
Data Maven Brings a History of Double-Digit Growth in Client Revenue to a Growing Strategy, Analytics and Media Team. - November 16, 2018 - Arteric